Nitta Gelatin India Limited (NITTAGELA) fundamentals
Nitta Gelatin India Limited is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as NITTAGELA (ISIN INE265B01019). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Nitta Gelatin India Limited does
Nitta Gelatin India Limited is an India-based company, which is engaged in the business of manufacturing and sale of Gelatin, Ossein, Di Calcium Phosphate (DCP) and Collagen Peptide. The Company’s products include Wellnex Collagen Peptides, Gelatin, Di Calcium Phosphate, Chitosan, and Consumer products. It offers Gelatin for Pharmaceutical and Food applications, Di-Calcium Phosphate as poultry feed ingredient, Ossein and Chitosan for Agricultural and Industrial applications. Its Wellnex Collagen Peptides products comprise Collagen Peptide Absorption, Wellnex for Diabetes Management, Wellnex for Beauty, and Wellnex for Bone and Joints. Its Gelatin products include Edible and Pharmaceutical. Chitosan is used in various industries, including food, pharmaceutical, textile, agriculture, water treatment and cosmetics industries. The Company’s subsidiary is Bamni Proteins Limited. The Company's plants are located at Thrissur, Ernakulam, Alappuzha, and Gujarat.
Valuation and market data
| Last close | ₹1650.00 |
|---|---|
| Market capitalisation | ₹1,514 crore |
| Enterprise value | ₹1,507 crore |
| P/E (TTM) | 15.40 |
| Price to book | 2.94 |
| Price to sales (TTM) | 1.48 |
| Book value per share | ₹561.95 |
| Dividend yield | 42.42% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Mon Apr 20 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹614 crore | ₹146 crore | ₹111 crore | 121.81 |
| Mar 2025 | ₹537 crore | ₹110 crore | ₹82 crore | 90.54 |
| Mar 2024 | ₹490 crore | ₹110 crore | ₹82 crore | 90.85 |
| Mar 2023 | ₹492 crore | ₹78 crore | ₹59 crore | 64.72 |
| Mar 2022 | ₹434 crore | ₹38 crore | ₹27 crore | 29.29 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 74.5% |
|---|---|
| Foreign institutions (FII) | 0.1% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.9% |
| Retail and others | 24.5% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.